Cargando…
Centralised Full Access to Clinical Study Data Can Support Unbiased Guideline Development, Continuing Medical Education, and Patient Information
Autores principales: | McGauran, Natalie, Wieseler, Beate |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8635651/ https://www.ncbi.nlm.nih.gov/pubmed/34868731 http://dx.doi.org/10.1080/21614083.2021.1989172 |
Ejemplares similares
-
From publication bias to lost in information: why we need a central public portal for clinical trial data
por: Wieseler, Beate, et al.
Publicado: (2022) -
Access to regulatory data from the European Medicines Agency: the times they are a-changing
por: Wieseler, Beate, et al.
Publicado: (2012) -
Impact of Inclusion of Industry Trial Results Registries as an Information Source for Systematic Reviews
por: Potthast, Regine, et al.
Publicado: (2014) -
A systematic comparison of different composite measures (DAS 28, CDAI, SDAI, and Boolean approach) for determining treatment effects on low disease activity and remission in rheumatoid arthritis
por: Janke, Kirsten, et al.
Publicado: (2022) -
Reporting bias in medical research - a narrative review
por: McGauran, Natalie, et al.
Publicado: (2010)